Difference between revisions of "Pre-Malignant Conditions"
(One intermediate revision by the same user not shown) | |||
Line 24: | Line 24: | ||
===Cervical Intraepithelial Neoplasia (CIN)=== | ===Cervical Intraepithelial Neoplasia (CIN)=== | ||
− | Acceptable at recruitment and VT if spontaneous resolution, or removed surgically or with cryo/laser therapy, with histologically confirmed Cervical Intra-epithelial Neoplasia (CIN) 1,2 or 3, and donor back on routine national screening programme. | + | RECRUITMENT AND VT - Acceptable at recruitment and VT if spontaneous resolution, or removed surgically or with cryo/laser therapy, with histologically confirmed Cervical Intra-epithelial Neoplasia (CIN) 1,2 or 3, and donor back on routine national screening programme. |
− | |||
===Familial Adenomatous Polyposis=== | ===Familial Adenomatous Polyposis=== | ||
− | Not Acceptable | + | RECRUITMENT - Not Acceptable |
− | If undergoing regular screening programme and no features of malignant change | + | VT - If undergoing regular screening programme and no features of malignant change may be acceptable. Discuss with MO and TC |
==Version== | ==Version== |
Latest revision as of 17:01, 9 June 2016
Contents
Acceptability at Recruitment
NOT ACCEPTABLE
Acceptability at CT / Work-Up
QUALIFIED, See below
Individual at Risk
Recipient
Explanation of Condition
Inherited conditions predisposing to risk of developing or transforming to malignancy
Guidance
Dependent on diagnosis, see below
BRCA1/BRCA2 Mutation
RECRUITMENT - Not Acceptable
VT - Acceptable if undergoing recommended screening. Inform TC at VT
All women should have a breast examination at medical
Cervical Intraepithelial Neoplasia (CIN)
RECRUITMENT AND VT - Acceptable at recruitment and VT if spontaneous resolution, or removed surgically or with cryo/laser therapy, with histologically confirmed Cervical Intra-epithelial Neoplasia (CIN) 1,2 or 3, and donor back on routine national screening programme.
Familial Adenomatous Polyposis
RECRUITMENT - Not Acceptable
VT - If undergoing regular screening programme and no features of malignant change may be acceptable. Discuss with MO and TC
Version
Version 1, Edition 1
Date of Last Update
1 June 2016